SCHEDULE 13G
0000315066
XXXXXXXX
LIVE
COMMON STOCK
06/28/2024
0001885522
Neumora Therapeutics, Inc.
640979100
490 ARSENAL WAY, SUITE 200
WATERTOWN
MA
02472
Rule 13d-1(c)
FMR LLC
DE
8622140.00
0.00
8622468.00
0.00
8622468.00
5.4
HC
Abigail P. Johnson
X1
0.00
0.00
8622468.00
0.00
8622468.00
5.4
IN
Neumora Therapeutics, Inc.
490 ARSENAL WAY, SUITE 200, WATERTOWN, MASSACHUSETTS, 02472.
FMR LLC
245 Summer Street, Boston, Massachusetts 02210
Not applicable
Y
8,622,468
5.405
Please see the responses to Items 5 and 6 on the cover page
0
8,622,468
0
Y
N
N
One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of NEUMORA THERAPEUTICS INC. No one other person's interest in the COMMON STOCK of NEUMORA THERAPEUTICS INC is more than five percent of the total outstanding COMMON STOCK.
N
See attached Exhibit 99.
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Please see Exhibit 99 for 13d-1(k) (1) agreement.
FMR LLC
Richard Bourgelas
Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
07/05/2024
Abigail P. Johnson
Richard Bourgelas
Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson*
07/05/2024
* This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on August 8, 2023, accession number: 0000315066-23-002397.